Why negative meta-analyses may be false?

European Neuropsychopharmacology

Volumn 23, Issue 10, 2013, Pages 1307-1309

  Hajek, Tomas ^a,b   Kopecek, Miloslav ^b   Alda, Martin ^a,b   Uher, Rudolf ^a   Höschl, Cyril ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

False negative; Meta analyses; Statistical heterogeneity

Indexed keywords

ACCURACY; ARTICLE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; META ANALYSIS (TOPIC); NEUROIMAGING; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY;

FALSE NEGATIVE; META-ANALYSES; STATISTICAL HETEROGENEITY;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; GENETIC ASSOCIATION STUDIES; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; NEUROIMAGING; PSYCHOPHARMACOLOGY; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE;

EID: 84884289788     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2013.01.004     Document Type: Article

References (17)

1. Belsky J., Jonassaint C., Pluess M., Stanton M., Brummett B., Williams R. Vulnerability genes or plasticity genes?. Mol. Psychiatry 2009, 14:746-754.
2. Fava G.A. Can long-term treatment with antidepressant drugs worsen the course of depression?. J. Clin. Psychiatry 2003, 64:123-133.
3. Geddes J., Freemantle N., Harrison P., Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. Br. Med. J. 2000, 321:1371-1376.
4. Hajek T., Cullis J., Novak T., Kopecek M., Hoschl C., Blagdon R., O'donovan C., Bauer M., Young L.T., MacQueen G., Alda M. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord. 2012, 14:261-270.
5. Hajek T., Kopecek M., Hoschl C., Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J. Psychiatry Neurosci. 2012, 37:110143.
6. Hajek T., Kopecek M., Kozeny J., Gunde E., Alda M., Hoschl C. Amygdala volumes in mood disorders-meta-analysis of magnetic resonance volumetry studies. J. Affect. Disord. 2009, 115:395-410.
7. Ioannidis J.P. Excess significance bias in the literature on brain volume abnormalities. Arch. Gen. Psychiatry 2011, 68:773-780.
8. Kempton M.J., Geddes J.R., Ettinger U., Williams S.C., Grasby P.M. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch. Gen. Psychiatry 2008, 65:1017-1032.
9. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008, 5:e45.
10. Kratochvil C.J., Vaughan B.S., Stoner J.A., Daughton J.M., Lubberstedt B.D., Murray D.W., Chrisman A.K., Faircloth M.A., Itchon-Ramos N.B., Kollins S.H., Maayan L.A., Greenhill L.L., Kotler L.A., Fried J., March J.S. A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics 2011, 127:e862-e868.
11. MacQueen G., Young T. Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar Disord. 2003, 5(Suppl. 2):53-61.
12. McDonald C., Zanelli J., Rabe-Hesketh S., Ellison-Wright I., Sham P., Kalidindi S., Murray R.M., Kennedy N. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol. Psychiatry 2004, 56:411-417.
13. Ruzickova M., Alda M. Antidepressants in bipolar depression: when less is more. J. Psychiatry Neurosci. 2002, 27:312.
14. Safer D.J. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J. Nerv. Ment. Dis. 2002, 190:583-592.
15. Sharma V. Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series. J. Affect. Disord. 2001, 64:99-106.
16. Usher J., Leucht S., Falkai P., Scherk H. Correlation between amygdala volume and age in bipolar disorder-a systematic review and meta-analysis of structural MRI studies. Psychiatry Res. 2010, 182:1-8.
17. Woodward N.D., Purdon S.E., Meltzer H.Y., Zald D.H. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizophr. Res. 2007, 89:211-224.